From: Plasma levels of the active form of suPAR are associated with COVID-19 severity
Patient type | Number of samples | Active suPAR (ng/mL) | hs-CRP (mg/L) | Neutrophil/leukocyte ratio (%) | Lymphocyte (×109/L) |
---|---|---|---|---|---|
Moderate | 57 | 4.57 ± 2.35 | 3.01 ± 3.67 | 59.98 ± 9.34 | 1.62 ± 0.60 |
Severe | 30 | 5.97 ± 2.31 | 38.79 ± 57.81 | 64.60 ± 11.23 | 0.97 ± 0.35 |
Critical | 21 | 6.68 ± 2.54 | 135.39 ± 93.88 | 87.49 ± 9.53 | 0.66 ± 0.37 |
Asymptomatic | 9 | 8.08 ± 4.81 | 1.29 ± 1.14 | 65.78 ± 9.30 | 1.57 ± 0.49 |